AXSOME THERAPEUTICS, INC. (AXSM) /

The debt of AXSOME THERAPEUTICS, INC. over the past 10 years

Chart AXSOME THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, AXSOME THERAPEUTICS, INC. had liquid cash of $322.93M and total debt of $187.75M: net cash of $135.19M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2025 ($187.75M) and lowest at the end of fiscal 2018 ($6.91M).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$322.93M$187.75M$135.19M
2024ended Dec 31, 2024$315.35M$180.71M$134.64M
2023ended Dec 31, 2023$386.19M$178.07M$208.12M
2022ended Dec 31, 2022$200.84M$94.26M$106.58M
2021ended Dec 31, 2021$86.47M$49.09M$37.38M
2020ended Dec 31, 2020$183.88M$48.32M$135.55M
2019ended Dec 31, 2019$219.97M$19.93M$200.03M
2018ended Dec 31, 2018$13.97M$6.91M$7.06M
2017ended Dec 31, 2017$34.02M$9.93M$24.09M
2016ended Dec 31, 2016$36.62M$9.74M$26.88M

Fiscal years as AXSOME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on AXSOME THERAPEUTICS, INC.

Companies of a similar size

Not investment advice. This page shows what AXSOME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.